You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biphenotypic leukemia CD19 in advanced remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Autologous Anti-CD19 CAR-expressing T Lymphocytes
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CD19 specific Chimeric Antigen Receptor T Cell
  • Columbus, Ohio
    Nationwide Children's Hospital
Mar 9, 2023

Acute Lymphoblastic Leukemia in Remission Trial in Suzhou (CD19 CAR-T cells and CD19 positive feeder T cells)

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • CD19 CAR-T cells and CD19 positive feeder T cells
  • Suzhou, Jiangsu, China
  • +2 more
May 18, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +5 more
  • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
  • +4 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Sep 22, 2022

Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Acute Lymphoblastic Leukemia
  • CD19 Directed CAR T Cell
  • Aurora, Colorado
    University of Colorado Hospital
Sep 12, 2022

Non-Hodgkin's Lymphoma (Disorder), Acute Lymphoid Leukemia, Disease (Disorder) Trial in Louisville, Houston (1A46 Injection)

Recruiting
  • Non-Hodgkin's Lymphoma (Disorder)
  • Acute Lymphoid Leukemia, Disease (Disorder)
  • 1A46 Injection
  • Louisville, Kentucky
  • +1 more
Aug 1, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

Terminated
  • B-cell Acute Lymphoblastic Leukemia
  • +7 more
  • RPM CD19-mbIL15-CAR-T cells
  • Taipei, Taiwan
    National Taiwan University Hospital
May 11, 2022

Platelet Transfusion Refractoriness, Acute Leukemia in Remission Trial in Suzhou (CAR-T infusion)

Recruiting
  • Platelet Transfusion Refractoriness
  • Acute Leukemia in Remission
  • CAR-T infusion
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 19, 2021

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Advanced Lymphoid Leukemia Trial in Worldwide (UCART19 follow-up)

Active, not recruiting
  • Advanced Lymphoid Leukemia
  • UCART19 follow-up
  • Los Angeles, California
  • +15 more
Apr 14, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia Not Having Achieved Remission, Acute Lymphoblastic

Unknown status
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • CD19-CAR-T2 Cells
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Oct 25, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
  • Antwerpen, Belgium
  • +21 more
Sep 27, 2021

Childhood Acute Lymphoblastic Leukemia Trial in Shijiazhuang (CD19 CAR-T, CD22 CAR-T, CD 19+22)

Recruiting
  • Childhood Acute Lymphoblastic Leukemia
  • CD19 CAR-T
  • +4 more
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
Nov 11, 2020

Adult B Acute Lymphoblastic Leukemia Trial in Shijiazhuang (CD19 CAR-T, CD22 CAR-T, CD19+CD22 CAR-T)

Recruiting
  • Adult B Acute Lymphoblastic Leukemia
  • CD19 CAR-T
  • +4 more
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
Nov 11, 2020

B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

Recruiting
  • B-Cell Non Hodgkin Lymphoma
  • B-Cell Acute Lymphoblastic Leukemia
  • anti-CD19 CAR T-cells
  • Hanoi, Vietnam
    Vinmec Research Institute of Stem Cell and Gene Technology
Sep 5, 2023

Acute Lymphoblastic Leukemia With Failed Remission Trial in Suzhou (CAR T-cell therapy)

Recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • CAR T-cell therapy
  • Suzhou, Jiangsu, China
    The Fisrt Affiliated Hospital of Soochow University
Jun 29, 2020

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • CD19/CD22-bispecific CAR-T cells
  • Beijing, Beijing, China
    Liang Wang
Oct 7, 2023

Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin Trial in Ribeirao Preto (CART-19)

Not yet recruiting
  • Leukemia, Acute Lymphoblastic
  • Lymphoma, Non-Hodgkin
  • CART-19
  • Ribeirao Preto, Sao Paulo, Brazil
    Ribeirao Preto School of Medicine, University of Sao Paulo
Oct 23, 2023

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (Metabolically Armed CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Metabolically Armed CD19 CAR-T cells
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Feb 17, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023